Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
India Glycols Limited is a leading Indian green chemical company that specializes in the manufacture of bio-based specialties and performance chemicals using renewable raw materials like molasses and ethanol. The company operates through three primary segments: Bio-based Specialties and Performance Chemicals, Potable Spirits, and Ennature Biopharma. Its Ennature Biopharma division is a significant player in the life sciences sector, focusing on the production of plant-based active pharmaceutical ingredients (APIs), standardized botanical extracts, and branded nutraceuticals for global markets. Key pharmaceutical products include high-purity Nicotine and Thiocolchicoside, while its nutraceutical portfolio features clinically validated ingredients like Maxicuma and Xanthogreen. Headquartered in Noida, India Glycols maintains state-of-the-art manufacturing facilities with global certifications including WHO-GMP and ISO, serving the pharmaceutical, healthcare, and food industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Indian Glycols.